Evidence map›Paper›PMID 36080091›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Templated Assembly of pH-Labile Covalent Organic Framework Hierarchical Particles for Intracellular Drug Delivery.

Fangzhou Zhou, Yuanyuan Fang, Chao Deng, Qian Zhang, Minying Wu, Hsin-Hui Shen, Yi Tang, Yajun Wang

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Fangzhou ZhouDepartment of Chemistry, Fudan University, Shanghai 200433, China.
Yuanyuan FangDepartment of Chemistry, Fudan University, Shanghai 200433, China.
Chao DengCollege of Chemistry & Materials Engineering, Wenzhou University, Wenzhou 325027, China.
Qian ZhangDepartment of Chemistry, Fudan University, Shanghai 200433, China.
Minying WuDepartment of Chemistry, Fudan University, Shanghai 200433, China.
Hsin-Hui ShenDepartment of Materials Science and Engineering, Monash University, Clayton, VIC 3800, Australia.
Yi TangDepartment of Chemistry, Fudan University, Shanghai 200433, China.
Yajun WangCollege of Chemistry & Materials Engineering, Wenzhou University, Wenzhou 325027, China.ORCID 0000-0002-7557-5883
Fudan University · CNWenzhou University · CNDivision of Materials Science and Engineering · AU

Funding

Foshan Science and Technology Innovation Project No. 2017IT100121National Key R&D Program of China 2018YFA0209402, 2018YFC1602301National Natural Science Foundation of China 22175132
6 · The paper itself

Abstract

Covalent organic frameworks (COF), a class of emerging microporous polymers, have been restrained for drug delivery applications due to their limited controllability over particle sizes and degradability. Herein, a dendritic mesoporous silica nanosphere (DMSN)-mediated growth strategy is proposed to fabricate hierarchical DMSN@COF hybrids through in situ growing of 1,3,5-tris(4-aminophenyl)benzene and 2,5-dimethoxyterephthaldehyde connected COF with acid cleavable C=N bonds. After the removal of the DMSN template, COF hierarchical particles (COF HP) with tailored particle sizes and degradability were obtained. Notably, the COF HP could be degraded by 55% after 24 h of incubation at pH 5.5, whereas the counterpart bulk COF only showed 15% of degradation in the same conditions. Due to the improved porosity and surface area, the COF HP can be utilized to load the chemotherapeutic drug, doxorubicin (DOX), with a high loading (46.8 wt%), outperforming the bulk COF (32.1 wt%). Moreover, around 90% of the loaded DOX can be discharged from the COF HP within 8 h of incubation at pH 5.5, whereas, only ~55% of the loaded DOX was released from the bulk COF. Cell experiments demonstrated that the IC

Indexed as

anticancercovalent organic frameworkdrug deliveryhierarchically porousmesoporous silicatemplated assembly

Identifiers

PMID36080091
PMCPMC9457862
OpenAlexW4295079119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.